Crbn I391V is sufficient to confer in vivo sensitivity to thalidomide and its derivatives in mice
Emma C. Fink(Broad Institute), Benjamin L. Ebert(Dana-Farber Cancer Institute), Namrata D. Udeshi(Harvard University), Andrew A. Guirguis(Peter MacCallum Cancer Centre), Tanya Svinkina(Broad Institute), Steven A. Carr(Broad Institute), Andrew Nguyen(Broad Institute), Saurav D. Haldar(Broad Institute), Marie McConkey(Broad Institute), Michelle Chen(Broad Institute), Brian Liddicoat(Broad Institute), James A. Kennedy(The University of Adelaide), D.R. Mani(Broad Institute)
Cited by 126
Related Papers
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
|Proceedings of the National Academy of Sciences|2005|56.5k
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease
|Science|2006|5.5k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k